ストックスクリーナーアプリを入手
340.43
0.83%
-2.84
アフターアワーズ：
340.00
-0.43
-0.13%
前日終値:
$343.27
開ける：
$343.05
24時間の取引高:
1.51M
Relative Volume:
1.26
時価総額：
$64.96B
収益：
$328.68B
当期純損益:
$2.55B
株価収益率:
26.12
EPS:
13.0349
ネットキャッシュフロー:
$1.56B
1週間 パフォーマンス:
+1.27%
1か月 パフォーマンス:
+7.56%
6か月 パフォーマンス:
+8.98%
1年 パフォーマンス:
+3.53%
1日の値動き範囲:
$338.34
$344.44
1週間の範囲:
$336.47
$345.46
52週間の値動き範囲:
$244.82
$377.54
Cencora Inc Stock (COR) Company Profile
Compare COR vs MCK, CAH, HSIC, AHG
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
COR
Cencora Inc
|
340.43 | 64.96B | 328.68B | 2.55B | 1.56B | 13.03 |
MCK
Mckesson Corp
|
1,015.50 | 118.40B | 403.43B | 5.10B | 5.41B | 38.47 |
CAH
Cardinal Health Inc
|
257.46 | 59.62B | 250.74B | 1.55B | 4.39B | 6.5398 |
HSIC
Henry Schein Inc
|
85.01 | 9.47B | 13.38B | 418.00M | 391.00M | 3.3112 |
AHG
Akso Health Group Adr
|
1.27 | 1.09B | 14.85M | -136.07M | 7.25M | -0.4726 |
Cencora Inc Stock (COR) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-08-19 | 開始されました | RBC Capital Mkts | Sector Perform |
| 2026-04-28 | 開始されました | William Blair | Mkt Perform |
| 2026-01-29 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
| 2026-01-22 | アップグレード | Jefferies | Hold → Buy |
| 2025-12-09 | 開始されました | Barclays | Overweight |
| 2025-06-03 | アップグレード | Wells Fargo | Equal Weight → Overweight |
| 2024-12-04 | 再開されました | Mizuho | Outperform |
| 2024-09-18 | ダウングレード | BofA Securities | Buy → Neutral |
| 2024-02-26 | 開始されました | Leerink Partners | Outperform |
| 2024-01-03 | 開始されました | Barclays | Overweight |
| 2023-12-14 | 開始されました | Wells Fargo | Equal Weight |
| 2023-03-31 | 開始されました | Citigroup | Buy |
| 2023-01-31 | 再開されました | Evercore ISI | Outperform |
| 2022-10-11 | アップグレード | BofA Securities | Neutral → Buy |
| 2022-08-22 | 再開されました | Morgan Stanley | Equal-Weight |
| 2022-07-11 | ダウングレード | Evercore ISI | Outperform → In-line |
| 2022-06-07 | アップグレード | Deutsche Bank | Hold → Buy |
| 2022-05-26 | アップグレード | Barclays | Equal Weight → Overweight |
| 2022-04-12 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2022-04-01 | 再開されました | Credit Suisse | Outperform |
| 2021-03-12 | 再開されました | Evercore ISI | In-line |
| 2021-02-04 | アップグレード | Evercore ISI | In-line → Outperform |
| 2021-02-02 | アップグレード | Cowen | Market Perform → Outperform |
| 2021-01-06 | アップグレード | BofA Securities | Underperform → Neutral |
| 2021-01-06 | アップグレード | Credit Suisse | Neutral → Outperform |
| 2020-12-10 | ダウングレード | Wells Fargo | Equal Weight → Underweight |
| 2020-12-03 | 開始されました | Mizuho | Neutral |
| 2020-08-06 | アップグレード | Raymond James | Mkt Perform → Outperform |
| 2020-07-15 | 開始されました | Barclays | Underweight |
| 2020-06-15 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
| 2020-04-23 | 再開されました | Credit Suisse | Outperform |
| 2020-04-16 | ダウングレード | Raymond James | Outperform → Mkt Perform |
| 2020-04-13 | ダウングレード | Robert W. Baird | Outperform → Neutral |
| 2020-04-01 | アップグレード | JP Morgan | Neutral → Overweight |
| 2020-03-17 | アップグレード | Citigroup | Neutral → Buy |
| 2020-02-11 | ダウングレード | BofA/Merrill | Buy → Underperform |
| 2020-02-07 | アップグレード | Robert W. Baird | Neutral → Outperform |
| 2019-09-12 | 開始されました | Deutsche Bank | Hold |
| 2019-07-10 | ダウングレード | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2019-04-11 | 開始されました | Guggenheim | Buy |
| 2019-04-10 | ダウングレード | BofA/Merrill | Buy → Underperform |
| 2019-04-10 | ダウングレード | Evercore ISI | Outperform → In-line |
| 2019-02-11 | ダウングレード | JP Morgan | Neutral → Underweight |
| 2019-01-17 | 開始されました | UBS | Buy |
| 2018-12-10 | ダウングレード | Jefferies | Buy → Hold |
| 2018-10-26 | ダウングレード | RBC Capital Mkts | Outperform → Sector Perform |
| 2018-09-20 | 開始されました | Berenberg | Buy |
| 2018-07-17 | 再開されました | Stifel | Hold |
| 2018-04-09 | 開始されました | MoffettNathanson | Buy |
| 2018-03-12 | アップグレード | KeyBanc Capital Mkts | Sector Weight → Overweight |
| 2018-03-12 | アップグレード | Raymond James | Mkt Perform → Outperform |
| 2017-09-25 | 開始されました | JP Morgan | Neutral |
| 2017-09-22 | 開始されました | William Blair | Outperform |
すべてを表示
Cencora Inc (COR) 最新ニュース
Amgen vs. Bristol Myers Squibb: Which Healthcare Stock Is a Better Buy in 2026? - The Motley Fool
Cencora stock: Cencora schedules November 4 results for Cencora stock - ad-hoc-news.de
Cencora, Inc. (COR) Stock Forecasts - Yahoo Finance
Cencora stock price target raised to $380 by Argus on growth outlook - Investing.com Canada
UBS cuts target to USD 400 for Cencora stock - ad-hoc-news.de
Cencora Inc. stock: drug distributor at EUR 303.60 ahead of the Xetra open - ad-hoc-news.de
Cencora stock: A 25.36 P/ E gives Cencora stock a valuation anchor - ad-hoc-news.de
Cencora stock trades at EUR 302.00 ahead of quarterly results - ad-hoc-news.de
Cencora Inc. Common Stock (COR) Company Profile - Pluang
ABC5748091 Bond Profile: Coupon and Redemption - TradingView
ABC6310086 Bond Profile: Coupon and Redemption - TradingView
Cencora (COR): 3 Reasons We Love This Stock - Yahoo Finance
Is Cencora (COR) Undervalued Or Is Raised Guidance Already Priced In? - Yahoo Finance
Cencora stock pre-market at EUR 304.65 - ad-hoc-news.de
Cencora Inc. stock outperforms competitors on strong trading day - MarketWatch
Cencora, Inc. (COR) Stock Forecasts - Yahoo! Finance Canada
AbbVie vs. Pfizer: Which Healthcare Stock Is a Better Buy in 2026? - The Motley Fool
Fund Update: 185,057 CENCORA (COR) shares added to FORT WASHINGTON INVESTMENT ADVISORS INC |OH| portfolio - Quiver Quantitative
Baird raises target for Cencora stock to USD 373.00 - ad-hoc-news.de
Cencora, Inc. (COR) Stock Forecasts - Yahoo Finance
Cencora Inc. stock outperforms competitors on strong trading day - MarketWatch
Cencora Currently Up Eight Days Straight, On Pace for Longest Winning Streak Since January 2025 -- Data Talk - Moomoo
AI Disruption May Benefit Cencora More Than Hims & Hers (NYSE:COR) - Seeking Alpha
Cencora Inc. stock outperforms competitors on strong trading day - MarketWatch
Cencora stock trades at EUR 291.90 with USD 63.3 billion value - ad-hoc-news.de
XS307124629 Bond Profile: Coupon and Redemption - TradingView
Cencora (COR) Has Investors Asking A Bigger Question - Simply Wall Street
Cencora appointed Robert Sanchez as analysts cite USD 372.07 target for Cencora stock - ad-hoc-news.de
US03073EBF16 Bond Profile: Coupon and Redemption - TradingView
ABC4571977 Bond Profile: Coupon and Redemption - TradingView
Cencora, Inc. (COR) Options Chain - Yahoo! Finance Canada
Cencora Inc. stock outperforms competitors on strong trading day - MarketWatch
If You Invested $1000 In Cencora Stock 10 Years Ago, You Would Have This Much Today - Benzinga
Cencora Inc (1COR.MI) Q3 FY2026 earnings call transcript - Yahoo Finance
ABC4213751 Bond Profile: Coupon and Redemption - TradingView
COR Maintained by Cencora -- Price Target Raised to $388 - GuruFocus
Form 4 Cencora Inc For: 6 October By Investing.com - Investing.com Nigeria
ABC6310083 Bond Profile: Coupon and Redemption - TradingView
Eli Lilly and vs. Novo Nordisk A/S: Which Healthcare Stock Is a Better Buy in 2026? - The Motley Fool
Cencora Remains A Buy At These Prices, As Healthcare Supply-Chain Needs Grow (NYSE:COR) - Seeking Alpha
Cencora Inc (COR) Insider Sale: SVP & Chief Accounting Officer L - GuruFocus
A 275-share stock grant for Cencora (COR) director Robert E. Sanchez vests in one year. - Stock Titan
Cencora Inc. R (ABG.MU) Q3 FY2026 earnings call transcript - Yahoo Finance
Cencora Inc. stock outperforms competitors on strong trading day - MarketWatch
Cencora Inc. stock outperforms competitors on strong trading day - MarketWatch
Under a trading plan, Cencora (COR) accounting chief sells 986 shares at $303.18 each. - Stock Titan
Cencora Announces Date and Time for Fourth Quarter Fiscal 2026 Earnings Release - marketscreener.com
Cencora Adds Ryder Veteran to Board as Logistics Focus Grows - MyChesCo
ABC6310082 Bond Profile: Coupon and Redemption - TradingView
Cencora (COR) Adds Robert E. Sanchez To Its Board, Is The Stock Still Cheap? - Simply Wall Street
Cencora Inc (COR) 財務データ
収益
当期純利益
現金流量
EPS
Cencora Inc (COR) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| GREENBERG LON R | Director |
Sep 16 '26 |
Sale |
321.30 |
1,280 |
411,264 |
17,128 |
| Lon Greenberg | Director |
Sep 16 '26 |
Proposed Sale |
321.31 |
1,280 |
411,282 |
0 |
| Battaglia Silvana | Former Officer |
Sep 11 '26 |
Proposed Sale |
325.00 |
1,324 |
430,300 |
0 |
| Cleary James F | Former Officer |
Sep 04 '26 |
Proposed Sale |
335.17 |
10,000 |
3,351,656 |
0 |
| Krikorian Lazarus | SVP & Chief Accounting Officer |
Sep 01 '26 |
Sale |
325.97 |
985 |
321,080 |
16,169 |
| Battaglia Silvana | Former Officer |
Sep 01 '26 |
Proposed Sale |
330.00 |
6,593 |
2,175,690 |
0 |
| Campbell Elizabeth S | Executive Vice President |
Aug 24 '26 |
Sale |
324.12 |
11,300 |
3,662,663 |
19,455 |
| Campbell Elizabeth S | Officer |
Aug 24 '26 |
Proposed Sale |
324.10 |
11,301 |
3,662,663 |
0 |
| Cleary James F | Officer |
Aug 06 '26 |
Proposed Sale |
316.65 |
20,000 |
6,333,096 |
0 |
| Tyler Lauren M | Director |
Jun 22 '26 |
Buy |
270.23 |
550 |
148,626 |
4,359 |
0.03%
0.39%
大文字化:
|
ボリューム (24 時間):